A Phase 1, Double Blinded, Placebo Controlled, Dose Comparison Trial to Evaluate the Safety, Immunogenicity and Schedule of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults
Phase of Trial: Phase I
Latest Information Update: 07 Feb 2019
Price : $35 *
At a glance
- Drugs Chikungunya virus vaccine (Primary)
- Indications Chikungunya virus infections
- Focus Adverse reactions; Pharmacodynamics
- 30 Jan 2019 Status changed from active, no longer recruiting to completed.
- 07 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 19 Oct 2017 Status changed from not yet recruiting to recruiting.